Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pulse oximeter accuracy put to the test in Low-Oxygen study

NCT ID NCT07408388

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study checks how accurately a pulse oximeter (a device that shines light through skin to measure blood oxygen) works during controlled low-oxygen breathing. About 48 healthy volunteers aged 18-50 will breathe a special gas mixture to safely lower their oxygen levels. Researchers will compare the device's readings to actual blood samples to see how well it performs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could improve the accuracy of pulse oximeters, leading to better monitoring of oxygen levels in patients.
What could go wrong
This is a small, early-stage study in healthy volunteers, so results may not apply to sick patients. The device may still have limitations in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy adult volunteers. At least 48 new subjects will be enrolled. Subjects will be selected with reference to ISO and FDA requirements to ensure appropriate representation across skin tone categories (Monk Skin Tone scale) and sex.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The subject is male or female, aged 18 to 50. * The subject is in good general health with no evidence of any medical problems * The subject is fluent in both written and spoken English. * The subject has provided informed consent and is willing to comply with the study procedures. Exclusion Criteria: 1. The subject has a BMI above 40 2. The subject has blood pressure above 160 systolic or 95 diastolic 3. The subject has a known history of heart disease, lung disease, kidney or liver disease. 4. Diagnosis of asthma, sleep apnea, or use of CPAP. 5. Subject has diabetes. 6. Subject has a clotting disorder. 7. The subject has a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation. (COHb\<3%, MetHb\<2%, ctHb\>10 g/dL). 8. The subject has any other serious systemic illness. 9. The subject has smoked in the last 12 hours. 10. Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators would interfere with the sensors working correctly. 11. The subject has a history of fainting or vasovagal response. 12. The subject has a history of sensitivity to local anesthesia. 13. The subject has a diagnosis of Raynaud's disease. 14. The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test). 15. The subject is pregnant, lactating or trying to get pregnant. 16. Subjects who have uneven skin tones at the forehead or the sensor site. 17. The subject is unable or unwilling to provide informed consent or is unable or unwilling to comply with study procedures. 18. The subject has any other condition, which in the opinion of the investigators would make them unsuitable for the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypoxia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vital Sign Research Group

    San Francisco, California, 94107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.